Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
Invasive meningococcal disease (IMD) is an acute life-threatening infection caused by the gram-negative bacterium, Neisseria meningitidis. Globally, there are approximately half a million cases of IMD each year, with incidence varying across geographical regions. Vaccination has proven to be success...
Saved in:
| Main Authors: | Georgina Tzanakaki, Hana Cabrnochová, Snežana Delić, Anca Draganescu, Anna Hilfanova, Beáta Onozó, Marko Pokorn, Anna Skoczyńska, Goran Tešović |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2301186 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity and safety of meningococcal vaccines, MenACWY-CRM and 4CMenB, in groups at increased risk for meningococcal disease
by: Shravani Bobde, et al.
Published: (2025-12-01) -
Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01) -
A new quadrivalent meningococcal tetanus toxoid conjugate vaccine: Menquadfi® (MENACWY-TT)
by: Ener Cagri Dinleyici, et al.
Published: (2025-12-01) -
Economic Evaluation of Adolescent Vaccination with Serogroup ACWY and C Meningococcal Vaccines in Germany
by: Sebastian Gruhn, et al.
Published: (2025-03-01) -
Safety of Tetravalent Conjugate Meningococcal Vaccine (Serotypes A, C, Y, W) for 1–4 Years Old Children With Distresses and Chronic Diseases in Closed Healthcare Facility: Cohort Study
by: Alebai U. Sabitov, et al.
Published: (2019-12-01)